Concepedia

Ole L. Dollerup

OL

Statistics

Publications

11

Citations

704

H-Index

11

Active since

2018

Affiliations

Aarhus University Hospital(Current)

Aarhus University

Steno Diabetes Centers

Novo Nordisk Foundation

University of Copenhagen

Ole L. Dollerup is an author at Aarhus University Hospital specializing in diabetes, health policy, and public health.

ORCID

Top concepts

Publications per year

2018–2023

11

Publications

11

A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects

Ole L. Dollerup, Britt Christensen, Mads Svart et al. · American Journal of Clinical Nutrition · 2018 · 273 citations · Full text

, , +11

Nicotinamide riboside does not alter mitochondrial respiration, content or morphology in skeletal muscle from obese and insulin‐resistant men

Ole L. Dollerup, Sabina Chubanava, Marianne Agerholm et al. · The Journal of Physiology · 2019 · 145 citations · Full text

Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity

Ole L. Dollerup, Samuel A.J. Trammell, Bolette Hartmann et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 83 citations · Full text

ChatGPT- versus human-generated answers to frequently asked questions about diabetes: A Turing test-inspired survey among employees of a Danish diabetes center

Ádám Hulmán, Ole L. Dollerup, Jesper Friis Mortensen et al. · PLoS ONE · 2023 · 61 citations · Full text

, , +24

A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals

Jonas Jensen, Ole L. Dollerup, Andreas Buch Møller et al. · JCI Insight · 2022 · 33 citations · Full text

1–5 of 11